SUBOXONE (BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE) SUBLINGUAL TABLETS Trademark

Trademark Overview

On Thursday, August 9, 2007, a trademark application was filed for SUBOXONE (BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE) SUBLINGUAL TABLETS with the United States Patent and Trademark Office. The USPTO has given the SUBOXONE (BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE) SUBLINGUAL TABLETS trademark a serial number of 77250847. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, July 5, 2011. This trademark is owned by Reckitt Benckiser Healthcare (UK) Limited. The SUBOXONE (BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE) SUBLINGUAL TABLETS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of opioid dependence
suboxone (buprenorphine hci/naloxone hci dihydrate) sublingual tablets

General Information

Serial Number77250847
Word MarkSUBOXONE (BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE) SUBLINGUAL TABLETS
Filing DateThursday, August 9, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, July 5, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 11, 2008

Trademark Statements

Indication of Colors claimedThe color(s) blue, green, and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE" AND A STYLIZED "C" WITH THREE VERTICAL LINES INSIDE AND "SUBLINGUAL TABLETS"
Description of MarkThe mark consists of the word "SUBOXONE" in blue with a green petal over the "ON" in "SUBOXONE". The chemical name of the mark ("Buprenorphine HCI/Naloxone HCI Dihydrate") appears in black underneath the word "SUBOXONE". To the right of the chemical name is a stylized "C" with three vertical lines inside, followed by the words "sublingual tablets" all in the color black.
Goods and ServicesPharmaceutical preparations for the treatment of opioid dependence

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 14, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameReckitt Benckiser Healthcare (UK) Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHull HU87DS
GB
Party NameReckitt Benckiser Healthcare (UK) Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHull HU87DS
GB

Trademark Events

Event DateEvent Description
Tuesday, July 5, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, July 5, 2011ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 23, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 22, 2010EXTENSION 5 GRANTED
Thursday, November 18, 2010EXTENSION 5 FILED
Thursday, November 18, 2010TEAS EXTENSION RECEIVED
Tuesday, May 25, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 24, 2010EXTENSION 4 GRANTED
Thursday, May 20, 2010EXTENSION 4 FILED
Thursday, May 20, 2010TEAS EXTENSION RECEIVED
Monday, March 8, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 8, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 1, 2009EXTENSION 3 GRANTED
Tuesday, November 24, 2009EXTENSION 3 FILED
Tuesday, November 24, 2009TEAS EXTENSION RECEIVED
Friday, June 19, 2009EXTENSION 2 GRANTED
Friday, May 29, 2009EXTENSION 2 FILED
Friday, June 19, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 29, 2009TEAS EXTENSION RECEIVED
Tuesday, December 2, 2008EXTENSION 1 GRANTED
Tuesday, December 2, 2008EXTENSION 1 FILED
Tuesday, December 2, 2008TEAS EXTENSION RECEIVED
Tuesday, June 3, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 11, 2008PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2008NOTICE OF PUBLICATION
Tuesday, February 5, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 31, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 31, 2008EXAMINER'S AMENDMENT ENTERED
Thursday, January 31, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 31, 2008EXAMINERS AMENDMENT E-MAILED
Thursday, January 31, 2008EXAMINERS AMENDMENT -WRITTEN
Monday, January 28, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 28, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 28, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 30, 2007COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Friday, November 30, 2007ASSIGNED TO LIE
Thursday, November 29, 2007NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, November 29, 2007EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, November 29, 2007EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, November 16, 2007ASSIGNED TO EXAMINER
Wednesday, August 15, 2007NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, August 14, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

sublingual tablets dihydrate naloxone buprenorphine suboxone dependence opioid treatment preparations pharmaceutical